Encompass Health Co. (NYSE:EHC) Stake Lessened by Janus Henderson Group PLC

Janus Henderson Group PLC lowered its holdings in Encompass Health Co. (NYSE:EHC) by 0.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,577,719 shares of the company’s stock after selling 2,665 shares during the period. Janus Henderson Group PLC owned approximately 1.57% of Encompass Health worth $152,518,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. UMB Bank n.a. boosted its position in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new stake in Encompass Health during the second quarter valued at $40,000. Avior Wealth Management LLC acquired a new stake in Encompass Health during the third quarter valued at $40,000. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on EHC shares. Barclays lifted their price objective on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. KeyCorp raised their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Truist Financial restated a “buy” rating and set a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Finally, UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Down 0.1 %

Encompass Health stock opened at $102.37 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The business’s 50-day simple moving average is $98.50 and its 200-day simple moving average is $91.69. The firm has a market capitalization of $10.31 billion, a PE ratio of 24.73, a PEG ratio of 1.35 and a beta of 0.86. Encompass Health Co. has a 52 week low of $64.15 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 earnings per share. Equities research analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.